mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
3e-13 |
mRNA |
nelarabine |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
4e-11 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
3e-09 |
mRNA |
FK866 |
GDSC1000 |
pan-cancer |
AAC |
0.2 |
4e-09 |
mRNA |
decitabine:carboplatin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
5e-08 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-07 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-07 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
WZ3105 |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
4e-07 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-06 |